Published in Transplant Proc on December 01, 1979
Histocompatibility matching. VI. Miniaturization of the mixed leukocyte culture test: a preliminary report. Transplantation (1971) 5.43
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. J Immunol (1977) 3.52
Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells. J Immunol (1979) 3.37
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35
Natural killer cells: characteristics and regulation of activity. Immunol Rev (1979) 3.14
Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature (1979) 2.94
Transplantation antigens: introductory symposium. Mixed leukocyte cultures and HL-A antigens. I. Reactivity of young fetuses, newborns and mothers at delivery. Transplant Proc (1971) 2.63
A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol (1977) 2.60
Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism. Proc Natl Acad Sci U S A (1982) 2.36
Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. J Immunol (1982) 2.30
Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol (1984) 2.21
Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition. J Exp Med (1976) 2.01
Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. Scand J Immunol (1975) 1.94
Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol (1977) 1.88
Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States. Am J Transplant (2011) 1.88
Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens (2004) 1.86
Continued growth of functional human T lymphocytes: production of human T-cell growth factor. Cell Immunol (1980) 1.63
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology (2002) 1.58
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
In vitro stimulation of murine spleen cells using a microculture system and a multiple automated sample harvester. J Immunol Methods (1973) 1.54
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab (1992) 1.51
NAT of the United States and Canadian blood supply. Transfusion (2000) 1.45
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood (1976) 1.40
Specific murine B-cell activation by synthetic single-and double-stranded polynucleotides. J Exp Med (1973) 1.37
Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high-incidence areas for the acquired immunodeficiency syndrome. Am J Epidemiol (1985) 1.37
Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization. J Exp Med (1974) 1.35
HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. Science (1988) 1.34
Detection of HLA-DRw (Ia-like) antigens on human T lymphocytes grown in tissue culture. J Immunol (1979) 1.33
Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity. J Immunol (1979) 1.32
Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines. J Exp Med (1973) 1.30
In vitro influenza virus-specific antibody production in man: antigen-specific and HLA-restricted induction of helper activity mediated by cloned human T lymphocytes. J Immunol (1982) 1.29
Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion (2005) 1.26
Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br Med J (Clin Res Ed) (1983) 1.26
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol (2000) 1.25
Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity. J Immunol (1983) 1.25
Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am (1995) 1.24
Plasma and spinal-fluid blocking factor in SSPE. N Engl J Med (1973) 1.23
Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1. Biochemistry (1982) 1.20
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group. Urology (2000) 1.19
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials. Eur Urol (2000) 1.17
Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgG. Int J Cancer (1979) 1.17
Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231. Hum Immunol (2000) 1.16
Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation. J Immunol (1984) 1.16
Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production. J Clin Invest (1975) 1.16
Cortical thickness and diaphysial diameter of the metacarpal bones from the age of three months to eleven years. Helv Paediatr Acta (1968) 1.16
Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. II. Evidenceth Kilham rat virus is responsible for the inhibitory effect. Cell Immunol (1977) 1.13
Cytotoxic activities of normal cultured human T cells. J Immunol (1978) 1.12
Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int J Cancer (1994) 1.12
Low T-lymphocyte ratios in homosexual men. Epidemiologic evidence for a transmissible agent. JAMA (1984) 1.10
The suppression of mitogen- and alloantigen-stimulated peripheral blood lymphocytes by cultured human T lymphocytes. J Immunol (1979) 1.09
Cell lines producing human T-cell lymphoma virus show altered HLA expression. Nature (1983) 1.09
Adverse reactions and events related to musculoskeletal allografts: reviewed by the World Health Organisation Project NOTIFY. Int Orthop (2011) 1.08
Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity. Blood (1980) 1.08
Regulation of immunoglobulin synthesis by dextran. J Exp Med (1973) 1.07
Effect of storage and preservation methods on viability in transplantable human skin allografts. Burns (2000) 1.06
Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells. Nature (1982) 1.03
SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones. Nature (1983) 1.02
Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody. J Allergy Clin Immunol (1978) 1.02
Immunological responsiveness of frozen-thawed human lymphocytes. Clin Exp Immunol (1975) 1.02
Recombination within the HLA-D region. Correlation of molecular genotyping with functional data. J Exp Med (1984) 1.00
Cell surface antigen expression in newborn cord blood lymphocytes infected with HTLV. J Immunol (1983) 0.98
Cultures of purified human natural killer cells: growth in the presence of interleukin 2. Cell Immunol (1982) 0.98
Primary structure of papain-solubilized human histocompatibility antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants. Biochemistry (1983) 0.98
CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood (1992) 0.98
Maintaining updated DNA-based HLA assignments in the National Marrow Donor Program Bone Marrow Registry. Rev Immunogenet (2000) 0.98
Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J Immunol (1983) 0.97
Specificity of in vitro murine B cell activation by protein and polysaccharide polymers. J Immunol (1974) 0.97
Long-term follow-up of patients with osteochondral allografts. A correlation between immunologic responses and clinical outcome. Orthop Clin North Am (1999) 0.97
Time-varying magnetic fields: effect on DNA synthesis. Science (1984) 0.97
Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. Cancer Treat Rep (1978) 0.96
Differential effects of interferon on the MHC expression of human lymphocytes. Enhanced expression of HLA without effect on Ia. Int Arch Allergy Appl Immunol (1979) 0.96
A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses. Eur J Cancer Clin Oncol (1982) 0.96
Lysis of cells infected with typhus group rickettsiae by a human cytotoxic T cell clone. J Immunol (1987) 0.95
Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia. J Clin Invest (1984) 0.93
Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2. Int J Cancer (1982) 0.93
Cryopreserved human cultured T cells as responder cells for the quantitative measurement of interleukin-2: improvement of the assay. J Immunol Methods (1982) 0.93
Calibration of a resonance energy transfer imaging system. Biophys J (1992) 0.92
A comparison of the effector cells involved in cell-mediated lympholysis and antibody-dependent cell-mediated cytotoxicity in man. Scand J Immunol (1975) 0.92
Mixed leukocyte cultures and HL-A antigens. II. Inhibition by anti-HL-A sera. Transplant Proc (1971) 0.92
Cytotoxicity inhibition studies using 3 M KCl solubilized murine histocompatibility antigens and a new multiple automated sample harvester. J Immunol Methods (1973) 0.91
Studies on the antigenicity of bone. I. Freeze-dried and deep-frozen bone allografts in rabbits. J Bone Joint Surg Am (1976) 0.91
Human helper T-cell clones that recognize different influenza hemagglutinin determinants are restricted by different HLA-D region epitopes. Immunogenetics (1984) 0.90
Cell-mediated immunity to friend virus-induced leukemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses. J Immunol (1976) 0.90
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia. Eur Urol (1992) 0.89
Antibacterial activity of a human monoclonal antibody to haemophilus influenzae type B capsular polysaccharide. Lancet (1982) 0.89
Decreased helper T lymphocytes in homosexual men. II. Sexual practices. Am J Epidemiol (1985) 0.88
Heterogeneity of T-CLL defined by monoclonal antibodies in nine patients. Clin Immunol Immunopathol (1982) 0.88
Antigen-specific human T-lymphocyte clones. Genetic restriction of influenza virus-specific responses to HLA-D region genes. Hum Immunol (1982) 0.88
Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. I. Characteristics of inhibition and evidence for an infectious agent. Cell Immunol (1977) 0.87
Proscar: five-year experience. Eur Urol (1995) 0.87
Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2. Tissue Antigens (1996) 0.86
The relative frequencies of HLA-DRB1*01 alleles in the major US populations. Tissue Antigens (2000) 0.86
Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity. J Natl Cancer Inst (1982) 0.86